C0012739 - Excessive activation of the body's coagulation system resulting in systemic microvascular thrombi formation. 2/10
home    UMLS 2020

293,031 терминов и синонимов из MeSH и LOINC

Поиск по CUI
Поиск по CODE


Поиск по одному или нескольким словам или частям слов
   


Lang   Dictionary       CODE         LUI      
preferred
no
       SUI   preference
Yes / No
Terms, descriptions
CUI    C0012739
RussianMedical Subject Headings Russian D004211 L3346850preferred S3874328 Y ДВС-СИНДРОМ
RussianMedical Subject Headings Russian D004211 L0892590no S1096407 Y DVS-SINDROM
RussianMedical Subject Headings Russian D004211 L1548697no S1844606 Y VNUTRISOSUDISTAIA KOAGULIATSIIA DISSEMINIROVANNAIA
RussianMDRRUS 10013441 L15723674no S19031298 Y Диссеминированное внутрисосудистое свертывание крови
RussianMDRRUS 10010785 L15747101no S19041544 Y Коагулопатия потребления
RussianMDRRUS 10012126 L15756849no S19030459 Y Дефибринационный синдром
RussianMDRRUS 10013429 L15756977no S19031300 Y Диссеминированное внутрисосудистое свертывание
RussianMDRRUS 10012769 L15767800no S19029725 Y ДВС
RussianMDRRUS 10013442 L15767974no S19031301 N Диссеминированное внутрисосудистое свёртывание крови
RussianMDRRUS 10013442 L15767974no S19031301 Y Диссеминированное внутрисосудистое свёртывание крови
RussianMDRRUS 10010786 L15778779no S19029724 Y ДВС-синдром
RussianMedical Subject Headings Russian D004211 L2392807no S2828803 Y DEFIBRINATSII SINDROM
RussianMedical Subject Headings Russian D004211 L2393549no S2829545 Y KOAGULOPATIIA POTREBLENIIA
RussianMedical Subject Headings Russian D004211 L2394821no S2830817 Y TROMBOGEMORRAGICHESKII SINDROM
RussianMedical Subject Headings Russian D004211 L3343076no S3870558 Y ВНУТРИСОСУДИСТАЯ КОАГУЛЯЦИЯ ДИССЕМИНИРОВАННАЯ
RussianMedical Subject Headings Russian D004211 L3347442no S3874921 Y ДЕФИБРИНАЦИИ СИНДРОМ
RussianMedical Subject Headings Russian D004211 L3352634no S3880117 Y КОАГУЛОПАТИЯ ПОТРЕБЛЕНИЯ
RussianMedical Subject Headings Russian D004211 L3372897no S3900390 Y ТРОМБОГЕМОРРАГИЧЕСКИЙ СИНДРОМ
Medical Subject Headings A0050422 AT100259026 A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS.
(CPTSP) CRISP Thesaurus A0477996 AT51224713 disorder characterized by reduction in the elements involved in blood coagulation due to their utilization in widespread blood clotting within the vessels; the activation of the clotting mechanism may arise from any of a number of disorders; in the late stages, it is marked by profuse hemorrhaging.
CHV A18553856 AT130671723 a disease where the blood clots throughout the body and increases the risk of bleeding
CHV A18665332 AT130671724 a disease where the blood clots throughout the body and increases the risk of bleeding
CHV A18665333 AT130671725 a disease where the blood clots throughout the body and increases the risk of bleeding
CHV A18683760 AT130671726 a disease where the blood clots throughout the body and increases the risk of bleeding
HPO A24675887 AT206286469 Disseminated intravascular coagulation is characterized by the widespread activation of coagulation, which results in the intravascular formation of fibrin and ultimately thrombotic occlusion of small and midsize vessels. [HPO:probinson, pmid:10451465, pmid:11816725]
NCI U.S. Food and Drug Administration A7570098 AT197979827 A disorder characterized by reduction in the elements involved in blood coagulation due to their utilization in widespread blood clotting within the vessels.
NCI Thesaurus A7570098 AT198054189 A pathological process where the blood starts to coagulate throughout the whole body. This depletes the body of its platelets and coagulation factors, and there is an increased risk of hemorrhage.
NCI Common Terminology Criteria for Adverse Events A7570098 AT198066387 A disorder characterized by systemic pathological activation of blood clotting mechanisms which results in clot formation throughout the body. There is an increase in the risk of hemorrhage as the body is depleted of platelets and coagulation factors.
NCI National Institute of Child Health and Human Development A7570098 AT210369873 Excessive activation of the body's coagulation system resulting in systemic microvascular thrombi formation.